Carcinoma, Embryonal: Clinical Trials

35 trials for Carcinoma, Embryonal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed, 3 recruiting, 2 terminated, 1 unknown. 18 Phase 2, 11 Phase 3, 4 Not applicable, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 218Completed 15, Recruiting 1, Terminated 1, Unknown 1
Phase 311Completed 8, Recruiting 1, Terminated 1, Unknown 1
Not applicable4Completed 4
Phase 13Completed 3

Follow Carcinoma, Embryonal: new trials by email Literature Review of Carcinoma, Embryonal trials Research Report on Carcinoma, Embryonal

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Molecular Epidemiology of Pediatric Germ Cell Tumors
Questionnaire Administration, Tumor Specimen Collection, Germline DNA Samples - Germ Cell Tumor, Germinoma
RecruitingChildren's Oncology Group11512023-04-122025-10-24
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Biospecimen Collection, Carboplatin, Etoposide - Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma
Phase 2RecruitingChildren's Oncology Group1602021-07-132026-09-23
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Best Practice, Biopsy Procedure, Biospecimen Collection - Childhood Extracranial Germ Cell Tumor, Extragonadal Embryonal Carcinoma
Phase 3RecruitingChildren's Oncology Group17802017-05-252026-08-25
Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors
Brentuximab Vedotin - Germ Cell Tumors, Testis Cancer
Phase 2TerminatedNabil Adra182016-03-092019-12-10
Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors
Brentuximab Vedotin - Germ Cell Cancer
Phase 2CompletedFondazione Michelangelo92013-05-012018-02-07
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
Carboplatin, Filgrastim, Ifosfamide - Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Malignant Germ Cell Tumor
Phase 2CompletedChildren's Oncology Group202007-11-052018-08-29
Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment
sunitinib malate - Extragonadal Germ Cell Tumor, Ovarian Cancer
Phase 2CompletedMemorial Sloan Kettering Cancer Center102007-03-012015-10-27
Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors
pegfilgrastim, cisplatin, ifosfamide - Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor
Phase 2CompletedMemorial Sloan Kettering Cancer Center602007-03-012017-11-28
Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
carboplatin, etoposide, ifosfamide - Childhood Germ Cell Tumor, Ovarian Cancer
Phase 2CompletedMasonic Cancer Center, University of Minnesota232006-12-192022-05-17
Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors
bleomycin sulfate, carboplatin, cisplatin - Extragonadal Germ Cell Tumor, Teratoma
Phase 2CompletedMedical Research Council882005-06-012013-08-26
Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors
bleomycin sulfate, pegfilgrastim, cisplatin - Extragonadal Germ Cell Tumor, Teratoma
Phase 2CompletedCambridge University Hospitals NHS Foundation Trust202004-08-012013-08-07
Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
cisplatin, ifosfamide, paclitaxel - Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
Phase 3TerminatedAlliance for Clinical Trials in Oncology12004-04-012016-07-04
Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors
bleomycin sulfate, cisplatin, etoposide - Extragonadal Germ Cell Tumor, Teratoma
Phase 3CompletedUNICANCER2632003-11-262025-02-06
Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors
ixabepilone - Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor
Phase 2CompletedMemorial Sloan Kettering Cancer Center292003-08-012013-06-24
Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer
ipilimumab, therapeutic allogeneic lymphocytes - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
Phase 1CompletedNational Cancer Institute (NCI)212003-04-012013-03-27
Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation
acupuncture therapy, management of therapy complications, pain therapy - Cancer
Not applicableCompletedNational Cancer Institute (NCI)2003-03-012015-04-30
Positron Emission Tomography in Detecting Testicle Cancer
positron emission tomography, fludeoxyglucose F 18 - Testicular Germ Cell Tumor
Not applicableCompletedInstitute of Cancer Research, United Kingdom2002-05-012013-12-18
Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
caspofungin acetate, liposomal amphotericin B - Cancer
Phase 3CompletedMemorial Sloan Kettering Cancer Center2000-08-012013-01-18
Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors
filgrastim, recombinant interleukin-11 - Breast Cancer, Gestational Trophoblastic Tumor
Phase 2CompletedFred Hutchinson Cancer Center2000-08-012010-04-02
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
beclomethasone dipropionate - Breast Cancer, Chronic Myeloproliferative Disorders
Phase 1 / Phase 2CompletedFred Hutchinson Cancer Center2000-07-012010-04-02

Showing 20 of 35. Sign in to see all of them.

Narrower conditions

Endodermal Sinus Tumor (32)  ·  Teratoma (32)  ·  Testicular Neoplasms (32)  ·  Seminoma (25)  ·  Teratoma, Testicular (19)  ·  Testicular Germ Cell Tumor (19)  ·  Breast Neoplasms (14)  ·  Burkitt Lymphoma (14)  ·  Carcinoma, Ovarian Epithelial (14)  ·  Hodgkin Disease (14)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (14)  ·  Lymphoma, Follicular (14)  ·  Lymphoma, Large B-Cell, Diffuse (14)  ·  Lymphoma, Large-Cell, Immunoblastic (14)

Broader conditions

Neoplasms by Histologic Type (35)  ·  Urogenital Diseases (34)  ·  Endocrine Gland Neoplasms (32)  ·  Endocrine System Diseases (32)  ·  Genital Diseases (32)  ·  Genital Diseases, Male (32)  ·  Genital Neoplasms, Male (32)  ·  Gonadal Disorders (32)  ·  Male Urogenital Diseases (32)  ·  Mesonephroma (32)  ·  Neoplasms by Site (32)  ·  Testicular Diseases (32)  ·  Urogenital Neoplasms (32)  ·  Neoplasms, Germ Cell and Embryonal (31)  ·  Neoplasms (26)

Interventions

Cisplatin (10)  ·  Etoposide (9)  ·  Ifosfamide (9)  ·  Filgrastim (8)  ·  Paclitaxel (8)  ·  Bleomycin (7)  ·  Carboplatin (7)  ·  Peripheral Blood Stem Cell Transplantation (4)  ·  Granulocyte Colony-Stimulating Factor (3)  ·  Magnetic Resonance Spectroscopy (3)  ·  Radiotherapy (3)  ·  pegfilgrastim (3)  ·  Brentuximab Vedotin (2)  ·  Cyclophosphamide (2)  ·  Mesna (2)

Sponsors

Fred Hutchinson Cancer Center (7)  ·  Memorial Sloan Kettering Cancer Center (5)  ·  Children's Oncology Group (4)  ·  European Organisation for Research and Treatment of Cancer - EORTC (3)  ·  Medical Research Council (2)  ·  National Cancer Institute (NCI) (2)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  Cancer Treatment Centers of America (1)  ·  City of Hope Medical Center (1)  ·  Eastern Cooperative Oncology Group (1)  ·  Fondazione Michelangelo (1)  ·  Indiana University (1)  ·  Institute of Cancer Research, United Kingdom (1)  ·  Masonic Cancer Center, University of Minnesota (1)

Countries

United States (27)  ·  United Kingdom (7)  ·  Australia (4)  ·  Canada (4)  ·  Italy (4)  ·  Slovakia (4)  ·  Belgium (3)  ·  France (3)  ·  Germany (3)  ·  Netherlands (3)  ·  Puerto Rico (3)  ·  Spain (3)  ·  Austria (2)  ·  Denmark (2)  ·  Hungary (2)

Top investigators

Robert J. Motzer, MD (4)  ·  Robert A. Huddart, MD (2)  ·  A. L Frazier (1)  ·  Alessandro M Gianni, MD (1)  ·  Anastasios Raptis, MD (1)  ·  Andrea Necchi, MD (1)  ·  Carlos Rodriguez-Galindo (1)  ·  Claude Sportes, MD (1)  ·  Costantine Albany, MD (1)  ·  Darren Feldman, MD (1)  ·  David Hockenbery, MD (1)  ·  Dean F. Bajorin, MD (1)  ·  Eric J. Small, MD (1)  ·  Ewa Carrier (1)  ·  Gedske Daugaard, MD, DMSc (1)

Results publications

PMID 15459300, PMID 15999102, PMID 17235042, PMID 17634488, PMID 18974373, PMID 19547919, PMID 21059637, PMID 25001888, PMID 25456363, PMID 37783480, PMID 39167741

NIH funding

U10CA180886 (2), 2005 (1), P30CA008748 (1), P30CA033572 (1), R01CA093891 (1), U10CA021115 (1), U10CA031946 (1), U10CA098543 (1)